Avastin/FOLFIRI in Combination With Curcumin in Colorectal Cancer Patients With Unresectable Metastasis
Status:
Completed
Trial end date:
2019-08-01
Target enrollment:
Participant gender:
Summary
Oral curcumin-containing supplement will be given to colorectal cancer patients with
unresectable metastases who will be starting Avastin/FOLFIRI chemotherapy for up to
completion of (or withdrawal from) chemotherapy.